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Summary 
The conserved invariant chain associates with highly 
polymorphic a and fl subunits guiding class II transport 
through the secretory pathway. Early associations of 
these three polypeptides inside antigen-presenting cells 
are poorly understood. The present experiments pro- 
vide a detailed picture of the structure and fate of class 
II Q and B subunits in invariant chain mutants pos- 
sessing different MHC haplotypes. In the absence of 
invariant chain, AabAfib is predominantly expressed as 
free Aab and Afib chains by both splenocytes and acti- 
vated LPS/IL-4 blasts, confirming that AabAflb assem- 
bly is strongly dependent on invariant chain coexpres- 
sion. A quite different situation exists with respect to 
other allelic products. In the absence of invariant 
chain, AakApk, EakEpk, and AadAfld molecules assemble 
efficiently and are conformationally similar to mature 
wild-type heterodimers. The contribution of invariant 
chain to subunit assembly thus differs for allelic vari- 
ants, suggesting that sequential associations of a, 13, 
and invariant chain may be affected by polymorphic 
differences. 
Introduction 
Two distinct categories of highly polymorphic membrane 
glycoproteins encoded at the major histocompatibility com- 
plex (MHC) play an essential role in the presentation of 
antigenic peptides to T lymphocytes. X-ray crystal studies 
have demonstrated that their overall three-dimensional 
structures are remarkably similar (Bjorkman et al., 1987; 
Brown et al., 1988, 1993; Stern et al., 1994). However, 
these two classes of MHC molecules show a striking diver- 
gence with respect to their intracellular transport routes 
and repertoires of associated peptide ligands (reviewed 
by Germain and Margulies, 1993). Assembly of tertiary 
complexes of class I H chains plus &microglobulin plus 
peptideoccurs at neutral pH within the endoplasmic reticu- 
lum (ER). Current models suggest the H chain initially as- 
sociates with 8,microglobulin to create an empty binding 
site (Ljunggren et al., 1990; Schumacher et al., 1990; De- 
gen et al., 1992; Ribaudo and Margulies, 1992; Bijlmakers 
et al., 1993; Neefjes et al., 1993) though H chain domain 
folding may also result from an earlier interaction with pep- 
tide (Elliott et al., 1991; Ribaudo and Margulies, 1992; 
Joyce et al., 1994). Incompletely folded class I intermedi- 
ates are transiently bound to the chaperone calnexin and 
the TAPl/TAPS peptide transporter (Degen et al., 1992; 
Neefjes et al., 1993; Suh et al., 1994; Ortmann, et al., 
1994). 
Although a great deal has been learned about peptide- 
dependent class I assembly, it has proven far more difficult 
to gain an equally sophisticated view of the complex cellu- 
lar and biochemical events necessary for class II peptide 
acquisition. In contrast with class I, class II peptide ligands 
are unnecessary for stable association of the a and 8 sub- 
units (Stern and Wiley, 1992; Altman et al., 1993; Bijlmak- 
ers et al., 1994a; Hedley et al., 1994). Instead class II a 
and 8 chains assemble as oligomeric complexes with a 
third polypeptide, the invariant chain, shortly after synthe- 
sis in the ER (Sung and Jones, 1981; Machamer and Cress 
well, 1982; Kvist et al., 1982). The association with invariant 
chain prevents peptide occupancy (Roche and Cresswell, 
1990, 1991; Teyton et al., 1990; Roche et al., 1992) pro- 
motes export through the secretory pathway (Layet and 
Germain, 1991; Anderson and Miller, 1992) and serves to 
escort class II molecules to peripheral endocytic vesicles 
where exposure to acidic pH and proteolytic enzymes pro- 
motes invariant chain degradation and peptide capture 
(Guagliardi et al., 1990; Baake and Dobberstein, 1990; 
Lotteau et al., 1990; Peterset al., 1991; Germain and Hen- 
drix, 1991; Roche and Cresswell, 1991; Neefjes and Ploegh, 
1992; Romagnoli et al., 1993; Amigorena et al., 1994; Tulp 
et al., 1994; Qiu et al., 1994). 
Considerable data suggest the highly conserved invari- 
ant chain associates with the peptide groove of polymor- 
phic a and 8 chains (reviewed by Cresswell, 1994; Ger- 
main, 1994). Several reports have described an invariant 
chain peptide commonly eluted from MHC class II mole- 
cules (Rudensky et al., 1991a, 1992; Hunt et al. 1992; 
Chicz et al., 1992, 1993). Recent experiments indicate 
this portion of invariant chain, the so-called CLIP region 
corresponding to amino acids 81-104, is critical for stable 
association with class II (Freisewinkel et al., 1993; Bijlmak- 
ers et al., 1994b; Romagnoli and Germain, 1994). Together, 
these observations imply that apl oligomeric complexes 
assemble via a universal pathway. On the other hand, 
allelic variants probably differ in the intrinsic stability of 
their a8 pairs or in the repertoire of self-peptides. The 
extensive polymorphism necessary to accomodate a di- 
verse set of peptides might be expected to dictate allele- 
specific invariant chain contact residues. Given these struc- 
tural issues, the question how the invariant chain universally 
assembles with polymorphic regions of class II a and 8 
subunits is particularly challenging. 
Significant progress towards understanding the various 
functions of invariant chain under normal physiological 
conditions has come from recent experiments analyzing 
invariant chain-deficient mice (Bikoff et al., 1993; Viville 
et al., 1993; Elliott et al., 1994). Spleen cells from the mu- 
tants all exhibited markedly reduced class II surface ex- 
pression, owing in large measure to decreased rates of 
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Figure 1. Predominantly Free Aab and APb Chains Expressed by Both 
Resting and Activated B Cells in the Absence of Invariant Chain 
(A-B) Cytoplasmic extracts prepared from splenocytes or LPSIIL-4 
blasts pulse-labeled for 40 min with [JH]leucine (A) and after a 4 hr 
chase period (8) were immunoprecipitated with MAbs or chain-specific 
rabbit antibodies as indicated. Complexes solubilized at 1OO“C (B) or 
at room temperature (NB) were analyzed by SDS-PAGE under reduc- 
ing conditions. C and F indicate the positions of compact and floppy 
up dimers, respectively. The apparent shift in serological reactivity 
observed for wild-type LPSAL-4 blasts is probably due to markedly 
increased amounts of AabABb being less efficiently captured by limiting 
amounts of M/l 14 in comparison with that recovered using Y3P at 
antibody saturation. 
post-ER export (Bikoff et al., 1993; Viville et al., 1993; 
Elliott et al., 1994). However, the notion that this also re- 
flects defective subunit assembly has been controversial. 
Although our experiments showed significantly reduced 
amounts of up heterodimers and consistently more free 
a and 8 chains expressed by mutant spleen cells, other 
evidence suggested an assembly-competent phenotype 
(Elliott et al., 1994). Results of early transfection experi- 
ments (Miller and Germain, 1986; Sekaly et al., 1986) and 
recent reports of recombinant class II produced in the ab- 
sence of invariant chain (Stern and Wiley, 1992; Altman 
et al., 1993; Bijlmakers et al., 1994a; Hedley et al., 1994) 
are all entirely consistent with this second possibility. 
It was, therefore, of considerable interest to reevaluate 
the possible contribution of invariant chain to assembly 
of a8 pairs and, in particular, to test the possibility that 
invariant chain dependency for subunit associations might 
differ for allelic variants. The present experiments used an 
extensive panel of serological reagents to obtain a clearer 
pictureof the structure and fate of class II a and 8 subunits 
in invariant chain mutants possessing different MHC hap- 
lotypes. In the absence of invariant chain, both spleno- 
cytesandactivated lipopolysaccharide/interleukin-4(LPS/ 
IL-4) blasts predominantly express free Aab and ABb 
chains, confirming earlier evidence that AabApb subunit 
assembly is strongly dependent on invariant chain coex- 
pression. A quite different situation exists with respect to 
other allelic products. In the absence of invariant chain, 
AakApk, EakEpk, and AadApd molecules assemble effi- 
ciently and are conformationally similar to mature wild- 
type heterodimers. Thus, the invariant chain contribution 
to a6 assembly differs for allelicvariants, suggesting these 
associations may occur via structurally distinct interme- 
diates. 
Results 
Invariant Chain Is Necessary for Optimal AabAflb 
Assembly in Resting and Activated B Cells 
We previously observed significantly reduced amounts of 
assembled AabABb and consistently more free Aab and ABb 
chains in invariant chain mutants, suggesting the invariant 
chain plays a critical role in production or maintenance 
of AabAPb dimers under normal physiological conditions 
(Bikoff et al., 1993). By contrast, other experiments sug- 
gested these mutants exhibit an assembly-competent 
phenotype (Elliott et al., 1994). Interestingly, in this case, 
AabAPb production was examined in activated B cells, 
whereas, by contrast, we analyzed resting splenocytes. 
IL-4 is known to be a potent up-regulator of class II and 
invariant chain mRNA expression (Pollaet al., 1986). LPSl 
IL-4 treatment was recently shown to increase production 
of compact AakApk dimers by invariant chain-deficient 
spleen cells (Viville et al., 1993). It was, therefore, of inter- 
est to determine whether defective assembly of AabAPb 
dimers might be rescued by B cell activation. 
FACS analysis showed markedly enhanced AabApb sur- 
face expression by both mutant and wild-type LPSIIL-4 
blasts, but the mutant cells still expressed far less surface 
AabAPb in comparison with wild type (data not shown). 
As shown in Figure lA, conformation-independent rabbit 
antibodies predominantly detected free Aab and Apb chains 
produced by both resting spleen cells and activated LPSl 
IL-4 blasts in the absence of invariant chain. In contrast, 
substantial amounts of AabApb dimers associated with the 
invariant chain were recovered from wild-type lysates. Un- 
der these conditions, the At&specific monoclonal antibody 
(MAb) M5/114 was unable to precipitate free ABb chains 
produced by the invariant chain mutants. These results 
demonstrate that invariant chain coexpression promotes 
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Figure 2. Discrete Populations of Peptide-Occupied AabAffb Molecules in the Absence of Invariant Chain 
(A-D) Lysates prepared from spleen cells labeled for 46 min with [5H]leucine and chased for 5, 10, or 16 hr in the presence of Ea 56-73 peptide 
(100 PM), or as a control medium alone as indicated, were immunoprecipitated with Y3P ([A] and [Cl) or Y-Ae ([B] and [D]) MAbs. Complexes 
solubilized at 166% (B) or at room temperature (NB) were analyzed by SDS-PAGE under reducing conditions. C and F indicate the positions of 
compact and floppy af3 dimers, respectively. 
optimal AabAf3 subunit assembly by both resting and acti- 
vated B cells. 
After 5 hrof chase, virtually all mature AabABb molecules 
produced by wild-type splenocytes migrate as compact 
dimers at approximately 56 kDa, whereas, by contrast, the 
few assembled dimersdetected in the mutants displayed a 
reduced mobility in SDS-PAGE, probably owing to the 
absence of a tightly associated peptide (Bikoff et al., 1993; 
Viville et al., 1993; Elliott et al., 1994; also Figure 16). 
Floppy I-Ab dimers were similarly expressed by mutant 
LPSIIL-4 blasts, but, in this case, we also observe a small 
amount of AabAPb migrating in the position expected for 
compact dimers (Figure 1B). Thus, 6 cell activation by 
LPSIIL-4 treatment has little effect on AabApb peptide oc- 
cupancy. 
Exogenously Added Peptide Ligand Rescues 
Mutant Compact AabAfib Dimers 
Because floppy conformers can be generated upon expo 
sure of compact dimers to low pH in the absence of peptide 
(Sadegh-Nasseri and Germain, 1991) AabApb molecules 
having reduced mobility on SDS gels might correspond 
to partially denatured compact dimers devoid of peptide 
(Dornmair et al., 1969; Dornmair and McConnell, 1990). 
Another possibility is that floppy AabAbb dimers potentially 
represent an unstable intermediate loosely occupied by 
an incompletely processed peptide (Sadegh-Nasseri and 
McConnell, 1969). In either case, floppy AabApb conform- 
ers should undergo a conformational change to become 
compact upon binding an appropriate peptide ligand. To 
test this, mutant spleen cells were pulse-labeled with 
PH]leucine and subsequently chased in the presence of 
Ea 56-73 peptide for increasing periods of time. As shown 
in Figures 2A and 2C, under these conditions we observed 
significant de novo appearance of compact dimers reac- 
tive with Y3P (a plus 6) MAb. We note with great interest 
the increased stability of compact AabApb dimers in com- 
parison with floppy AabApb molecules at long periods of 
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Figure 3. AakAbk and EakEBk Dimers Assembled in the Absence of Invariant Chain Express Conformational Epitopes Contributed by Both Chains 
(A-D) Lysates prepared from spleen cells pulse-labeled for 40 min with PHjleucine (A-B) and chased for 5 hr (C-D) in the presence of HEL 46- 
61 peptide (100 pM), or as a control medium alone, were immunoprecipitated with MAbs or chain-specific rabbit antibodies as indicated (A-B), 
with H116-32 (C) or 11-5-2 (D) MAb. Complexes solubilized at 100% (8) or at room temperature (NB) were analyzed by SDS-PAGE under reducing 
chase. These results strengthen the evidence that class 
II molecules tightly associated with peptide ligands are 
relatively long-lived inside antigen-presenting cells (Ger- 
main and Hendrix, 1991; Nelson et al., 1994). 
To visualize more clearly peptide-occupied AabApb mol- 
ecules, we analyzed exactly the same lysates as above 
using the Y-Ae MAb specific for combinatorial determi- 
nants created by the association of AabAPb with the Ea 
56-73 peptide (Murphy et al., 1989, 1992; Rudensky et 
al., 1991 b). Wild-type Y-Ae+ molecules migrated in the po- 
sition expected for mature compact dimers regardless 
whether peptide occupancy occurred via the endogenous 
pathway as in BlO.A@R) spleen cells, or in the presence 
of exogenously added Ea 56-73 (Figures 2B and 2D). In 
the absence of invariant chain, two discrete populations 
of peptide-occupied AabApb molecules were routinely ob- 
served in SDS-PAGE. Heat treatment yielded an upper 
band migrating slightly more slowly than the wild-type ma- 
ture Aab chains. This species closely resembles the abnor- 
mally large Aad chains previously described in I-Ad-trans- 
fected EL4 lymphoma cells in the absence of invariant 
chain shown to arise as a result of alternative processing 
of N-linked glycans (Anderson and Miller, 1992). Thus, in 
cells lacking invariant chain, exogenously added Ea 56 
73 peptide can become tightly associated with twodiscrete 
species of AczbAPb dimers. Floppy AabAPb molecules 
showed no reactivity with the YAe MAb. The lower band 
visible at long periods of chase (16 hr) probably represents 
a partial degradation product. 
Native Structure of Newly Assembled AakAflk and 
EakEflk Dlmers in the Absence of Invariant Chain 
Viville et al. (1993) recently described AakAPk molecules 
produced by invariant chain mutant spleen cells. It seemed 
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Figure 4. Exposure of Native AadAbd Structure in the Absence of In- 
variant Chain Coassembly 
(A-B) Lysates prepared from spleen cells pulse-labeled for 40 min 
with PH]leucine (A) and after a 4 hr chase period (B) were immunopre- 
cipitated with MAbs or chain-specific rabbit antibodies as indicated. 
Complexes solubilized at 100°C (6) or at room temperature (NB) were 
analyzed by SDS-PAGE under reducing conditions. 
possible that invariant chain dependency for subunit as- 
sembly might prove to be AabApb specific. To test this, we 
decided to evaluate the amounts of assembled a6 dimers 
in comparison with free a and 6 chains produced by spleen 
cells from invariant chain mutants expressing different 
MHC haplotypes. To distinguish properly folded al 61 do- 
mains from possibly nonspecifically aggregated subunits, 
we used a wide panel of conformationally dependent MAbs 
directed against nonoverlapping epitopes contributed by 
both chains. To determine quantitatively the amount of 
free a and 6 chains, we analyzed these lysates using rabbit 
antisera raised against peptides present in the cyto- 
plasmic tails of a and 6 chains (Sant et al., 1991). 
As shown in Figures 3A-3B, apI complexes produced 
by wild-type BlO.BR spleen cells were reactive with the 
entire panel of conformationally dependent MAbs, and 
similarly in invariant chain mutants, these antibodies all 
coprecipitated stoichiometric amounts of Aa’ and Apk 
chains. Thus, in contrast with the situation for AabApb, 
AakAPk dimers are efficiently assembled in the absence 
of invariant chain. This conclusion was confirmed in pre- 
clearing experiments similar to those undertaken pre- 
viously using these chain-specific rabbit antibodies (data 
not shown). Although less extensively analyzed, observa- 
tions made for the EakEpk allelic product similarly show 
equivalent amounts of EakEBk dimers produced by mutant 
spleen cells (see Figures 3A-3B). Newly assembled EakE6” 
molecules in the absence of invariant chain express 408 
and 1444 epitopes. Indeed, 1444 (Ea specific) showed 
greater reactivity towards EakEpk dimers produced by cells 
lacking the invariant chain. Thus, the invariant chain is 
necessary for optimal AabApb subunit associations, but this 
activity is not required for assembly of other allelic products. 
As expected, export of assembled AakApk dimers to the 
cell surface was markedly decreased, and there was no 
evidence for compact AakApk dimers stably occupied by 
peptide ligands in the absence of invariant chain coexpres- 
sion (Viville et al., 1993; Figures 3C-3D). In contrast with 
the situation for AabApb, we failed to observe here the 
appearance of a structurally distinct population of AakApk 
floppy dimers using 1 O-2-1 6 (Apk specific), H116-32 (Au” 
specific), or 1 l-5-2 (Auk specific) MAbs (Figures 3C-3D; 
data not shown). Several mutant-specific bands were heat 
dissociable, but none of these migrated in a position appro- 
priate for floppyAakAf3k conformers. These higher molecu- 
lar weight species therefore probably represent nonspecif- 
ically aggregated or partially assembled AakApk dimers 
associated with ER chaperones. 
Conformational Analysis of AadABd Dlmers 
Produced by Cells Lacking Invariant Chain 
To investigate further the polymorphic differences affect- 
ing early class II biosynthesis, we next examined a third 
independent allele. The invariant chain mutation was intro- 
duced into BALB/c mice expressing the H-P haplotype. 
FACS analysis using several MAbs demonstrated mark- 
edly reduced class II surface antigens expressed by BALB/c 
invariant chain mutants (data not shown). As shown in Fig- 
ure 4A in pulse-labeling experiments, newly synthesized 
AadABd molecules produced by mutant spleen cells were 
reactive with several MAbs, including 25-9-17 (A6 spe- 
cific), MKD6 (Apd specific) and K24-199 (Aa specific). 
Although conformation-independent rabbit antibodies de- 
tected similar amounts of assembled AadApd dimers pro- 
duced by mutant and wild-type spleen cells, the wild-type 
a61 complexes were inefficiently precipitated using several 
MAbs specific for conformational epitopes, suggesting asso- 
ciation with the invariant chain sterically blocks MAb ac- 
cess to these discrete sites. The present results are in con- 
trast with previous experiments analyzing I-Ad expressing 
EL4 lymphoma cells, suggesting K24-199 and 408 MAbs 
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were specifically reactive with invariant chain-dependent 
epitopes (Peterson and Miller, 1990; Anderson and Miller, 
1992; Bikoff, 1992). These serologically different profiles 
could, in principle, be shaped by divergent class II path- 
ways in distinct cell types. As shown in Figure 46, there 
were no mature compact AadABd dimers produced by mu- 
tant spleen cells. Additionally, a discrete population of 
structurally distinct floppy AadAgd dimers was not observed. 
The overall shape of the peptide binding site present on 
class II molecules closely resembles that of class I, but, 
in contrast, this groove is not tightly occupied by peptides 
in the ER. Instead, highly polymorphic class II a and 8 
subunits assemble as oligomeric complexes with the con- 
served invariant chain. Considerable effort has been di- 
rected towards understanding the structural features re- 
sponsible for guiding early interactions of these three 
polypeptides. 
There are conflicting data in the literature regarding the 
preferred order of assembly of class II a, 8, and the invari- 
ant chain. Some studies have demonstrated that invariant 
chain binds free a (Kvist et al., 1982; Lotteau et al., 1990; 
Teyton et al., 1990; Anderson and Cresswell, 1994) or 
8 chains (Buerstedde et al., 1988; Teyton et al., 1990). 
Particularly in cells lacking invariant chain, partially folded 
class II a and 8 subunits form high molecular weight aggre- 
gates (Bonnerot et al., 1994; Elliott et al., 1994) making 
it difficult to distinguish these possibly bonafide intermedi- 
ates and nonspecific complexes. Considerable evidence 
suggests that the a81 complex is a nine subunit structure 
generated via the progressive addition of three a8 dimers 
to a core invariant chain trimer (Roche et al., 1991; Lamb 
and Cresswell, 1992). Consistent with this, in vitro transla- 
tion assays have failed to demonstrate a or 8 chains singly 
associated with invariant chain (Bijlmakers et al., 1994a; 
Hedley et al., 1994). Moreover, numerous experiments 
analyzing transfected cell lines have described class II 
heterodimers produced by cells lacking invariant chain 
(Miller and Germain, 1988; Sekaly et al., 1988; Peterson 
and Miller, 1990; Layet and Germain, 1991; Anderson and 
Miller, 1992; Bikoff, 1992). 
It was, therefore, quitesurprising toobserve significantly 
reduced amounts of assembled AabAPb dimers and con- 
sistently morefreeAabandAfibchainsexpressed by invari- 
ant chain mutants, suggesting the invariant chain plays 
a critical role in the production or maintenance of AabApb 
dimers under normal physiological conditions(Bikoff et al., 
1993). The present experiments confirm invariant chain 
expression is necessary for optimal AabApb assembly. 
Both resting and activated B cells exhibit this assembly- 
defective phenotype, supporting our recent suggestion 
that invariant chain functions as a true molecular chaper- 
one, promoting and stabilizing AabAPb subunit interac- 
tions. Elliott et al. (1994) using MU114 MAb to assess 
AabAPb expression may simply have detected the few 
assembled AabApb dimers, instead of the entire pool of 
AabApb molecules. 
A strikingly different situation exists with respect to sub- 
unit assembly of other allelic products. We found AakABk, 
EakEpk, and AadABd molecules efficiently assembled in the 
absence of invariant chain were conformationally similar 
to wild-type a8 heterodimers. Previous experiments by Vi- 
ville et al. (1993) described AakAftk molecules expressed 
by invariant chain mutants. The present study establishes 
that these AakAflk molecules, as well as EakEf3’and AadABd 
dimers, are properly folded as judged by their expression 
of conformational determinantscontributed by both a and 
8 chains. Moreover, nonspecific aggregation of the sub- 
units (Bonnerot et al., 1994; Elliott et al., 1994) cannot 
account for the present results, because stoichiometric 
amounts of a and 8 chains were coprecipitated using 
MAbs against spatially separate determinants. It is intrigu- 
ing that several conformationally dependent MAbs ineffi- 
ciently detect newly assembled wild-type AadApd dimers 
associated with invariant chain. Recent reports similarly 
describe decreased Y3P reactivity towards invariant chain- 
associated AabAPb molecules (Elliott et al., 1994; Romag- 
noli and Germain, 1994). The simplest explanation is that 
these epitopes lay buried beneath the invariant chain, but 
more complicated scenarios, such as conformational 
changes affecting domain orientation or side chain con- 
tacts upon association with invariant chain, cannot be 
ruled out. Overall, these results clearly illustrate difficulties 
one might expect to encounter using these MAbs as tools 
to study class II assembly and intracellular transport. 
Restricted pairing of allelically and isotypically matched 
a and 9 chains as described in transfected cell lines (Ger- 
main et al., 1985; Sant et al., 1987; Sant and Germain, 
1989; Karp et al., 1990; Braunstein et al., 1990) and trans 
genie mice (LeMeur et al., 1989) imposes strict limitations 
on the assembly of mismatched dimers. These previous 
experiments demonstrated that polymorphic sequences 
located in al 91 domains control the efficiency of ab pair- 
ing. Haplotype-mismatched class II dimers were espe- 
cially dependent on invariant chain for transport past the 
cis-Golgi (Layet and Germain, 1991) and, in its absence, 
were largely retained in the ER (Sant et al., 1991). In con- 
trast, here the invariant chain contributes to subunit asso- 
ciations of a particular allelically matched a8 pair. Thus, 
assembly of AabAPb but not other allelic variants was 
strongly dependent on invariant chain coexpression. The 
particular inability of Aaband APbchains to associate stably 
as dimers in the absence of invariant chain clearly distin- 
guishes AabApb from other class II molecules examined 
thus far. In this case, invariant chain may promote al91 
domain folding of otherwise unstable AabAPb dimers, or 
shift the dynamic equilibrium to favor a and 8 associations. 
Recent experiments analyzing recombinant class II mole- 
cules similarly demonstrate that the intrinsic stabilities of 
af3 dimers differs for allelic variants (Kozono et al., 1994). 
One possibility is that a81 complexes are assembled via 
structurally distinct intermediates. The experiments above 
suggest that invariant chain might form oligomeric com- 
plexes with assembled AakAPk, EakEpk, and AadApd di- 
mers, and yet associate with free Aab and Apb chains to 
promote their coassembly. Thus, the exact order of associ- 
ations amongst class II a, 9, and invariant chain may de- 
pend to a great extent on the particular class II molecule 
being studied. 
g,s.s II Subunit Assembly 
The present experiments demonstrate that the high de- 
gree of polymorphism necessary to accomodate a diverse 
set of peptides also dictates varying degrees of invariant 
chain dependency during class II subunit assembly. Strik- 
ing allelic differences also exist with respect to the ratio 
of unstable/compact dimers constitutively produced by 
normal spleen cells (Germain and Hendrix, 1991). Al- 
though greater than 90% of AabApb migrates in SDS- 
PAGE as compact dimers, this population represents a 
much smaller percentage of mature AakAbk and AadABd 
molecules in the steady state. The accumulation of AabApb 
floppy conformers on the surface of cells lacking invariant 
chain expression also stands in contrast with our findings 
for other allelic products. Under exactly the same experi- 
mental conditions using several MAbs specific for nonover- 
lapping epitopes, we have not been able to demonstrate 
similarly floppy conformers of other class II molecules. In 
light of the evidence that floppy dimers can be generated 
in vitro due to partial denaturation of compact dimers with 
accompanying peptide loss (Sadegh-Nasseri and Ger- 
main, 1991), it is tempting to speculate that the limited 
export of assembled AabApb dimers to the cell surface in 
the absence of invariant chain may reflect occupancy of 
their combining sites. 
In contrast with varying degrees of invariant chain de- 
pendency obsenred for subunit assembly, class II mole- 
cules produced by invariant chain mutants all universally 
exhibit defective post-ER transport (Viville et al., 1993; 
Bikoff et al., 1993; Elliott et al., 1994). This probably re- 
flects the essential contribution of invariant chain to their 
efficient release from ER resident chaperones. Incom- 
pletely assembled T cell receptors (Hochstenback et al., 
1992), partially folded MHC H chain-P2-microglobulin 
complexes (Degen et al., 1992; Neefjes et al., 1993; Orl- 
mann et al., 1994), as well as class II in the absence of 
invariant chain (Schaiff et al., 1992; Bonnerot et al., 1994; 
Nijenhuis and Neefjes, 1994; Anderson and Cresswell, 
1994), all transiently associate with molecular chaper- 
ones, such as BiP and calnexin, thought to be responsible 
for quality control in the ER. It is widely accepted that this 
category of molecules acts overall to prevent export of 
incompletely assembled or misfolded receptors to the cell 
surface. In contrast, the invariant chain functions exclu- 
sively as a class II escort, and is not found associated with 
other partially assembled complexes. The one particularly 
intriguing exception is its interaction with H-2Db H chains 
in T2 cells lacking the TAPl/TAP2 peptide transporter 
(Cerundolo et al., 1992). Interestingly, these incompletely 
assembled H-2lY molecules refolded upon addition of 
peptide ligand released the invariant chain, suggesting 
the unoccupied H-2Db peptide groove may structurally re- 
semble allele-specific pocket(s) created during associa- 
tion of class II a and p chains. 
In the absence of peptide, soluble class II molecules 
produced in insect cells (Stern and Wiley, 1992), as well 
as ap dimers released from apl complexes (Germain and 
Rinker, 1993), become highly aggregated. It seems likely 
that the class II-associated invariant chain acts to prevent 
irreversible misfolding of the empty peptide groove in the 
ER. The highly conserved invariant chain might, therefore, 
be expected to contact polymorphic side chains located 
in the binding site. Structural differences affecting ordered 
associations of allelically and isotypically diverse class II 
molecules with the invariant chain are expected to have 
a significant impact on selection of self-peptides. 
Experimental Procedures 
Anlmcllo 
The generation of invariant chain-deficient mice and polymerass 
chain reaction (PM) genotyping assay were previously described 
(Bikofl et al., 1993). In brief, a primer specific for the B’junction trag- 
merit (5’-GGCTAGGTCCCAGTGTAGGCX) in combination with a wild 
type-specific sequence contained within the deletion (Y-TCACTCA- 
AGGCAACCCTGC-39 and a neo primer (&CGCTGACAGCCGGAA- 
CACGG-3’) were used to distinguish wild-type and mutant alleles. Re- 
actions were carried out for 1 min at 94%. 2 min at 66%. and 3 min 
at 72% for 30 cycles, and the amplification products were visualized 
by ethidium bromide staining on a 0.8% agarose gel. The mutation 
was originally established on a (129 x C57BU6)FB background, both 
strains expressing the H-2b haplotype. Mutants were backcrossed to 
BlO.BRISgSn (H-27, BALBlc (H-p), or B.C.9, a strain congenic with 
C57BU6 but expressing the Igh’allotype of BALB/c, and the offspring 
typed for H-2 using a PCR screen developed by L. Berg (Harvard 
University, Cambridge, Massachusetts). The reaction contains three 
primers corresponding lo a conserved sequence in Ea intron 1 
(5‘.CATAGCCCCAAATGTCTGACCTCTGGAGAG-33, a sequence up- 
stream of the Ea promoter (5’.AGTCTTCCCAGCCTTCACACTCA- 
GAGGTAC-3’) and a sequence lying within the Ea deletion characteris- 
tic of H-2 mice (SXATGGGCATAGAAAGGGCAGTCTITGAACT-3?. 
Following 30 cycles of amplification for 1 min at 94W, 1 min at 56OC, 
and 1.5 min at 72OC, the 155 bp H-2b and 210 bp H-2k/H-2d products 
were resolved on a 3% agarose gel. Backcross progeny typed as 
homozygous with respect to H-2 were intercrossed to produce the 
invariant chain mutants and wild-type littermates used in the present 
study, and sublines were subsequently established at the sixth back- 
cross generation. 
Antlbodles and Peptldes 
Rabbit antisera specific for determinants located in the cytoplasmic 
tails of the a and B chains have been described (Sant et al., 1991). 
M5/114(Bhattacharyaetal., 1961), lO-2-16and 11-5-2(Dietal., 1976), 
and MKD6 (Kappler et al., 1961) were obtained from the American 
Type Culture Collection (Rockville, Maryland). Y-Ae (Murphy et al., 
1969) and Y3P (Janeway et al., 1964) were provided by C. A. Janeway, 
Jr. (Yale University Medical School, New Haven, Connecticut) and Il. 
Murphy (New York State Department of Health, Albany, New York). 
14-4-4 (Ozato et al., 1960) and 25-9-l 7 (Ozato and Sachs, 1961) were 
from K. Ozato, National Institutes of Health, Bethesda, Maryland 
H116-32 (Hammerling et al., 1979) and K24-199 (Koch at al., 1992) 
were obtained from G. Hammerling, German Cancer Resarch Center, 
Heidelberg, Federal Republic of Germany. 408 (Pierres et al., 1961) 
was provided by M. Pierres, Centre d’lmmunologie lnstitut National de 
la Sante et de la Recherche MBdicale, Centre National de la Recherche 
Scientifique, Marseille, France. The chain specificities of these MAbs 
as determined using L cell transfectants and discussed throughout 
the text have been summarized (Landais et al., 1966; Braunstein et 
al., 1990). The Ea 5673 (ASFEAQGAIANIAVDKA) and HEL 46-61 
(NTDGSTDYGILQINSR) peptides were purchased from Quality Con- 
trolled Biochemicals, Incorporated (Hopkinton, Massachusetts). 
LPSIIL-4 Treatment 
Spleen cells treated with Tris-HCI to lyse red blood cells were cultured 
(2 x 10Yml) for 46 hr at 37OC in complete RPM1 1640 supplemented 
with 10% NCTC109, 15% fetal calf serum, 2 mM glutamine. 0.1 mM 
nonessential amino acids, 100 U/ml penicillin, 100 pg/ml streptomycin, 
1 mM sodium pyruvate, 15 mM HEPES (pH 7.2), 5 x lo-” M2- 
mercaptoethanol, in the presence of LPS Escherichia coli OX-85 
(Difco Laboratories, Detroit, Michigan) (50 &ml) and recombinant 
mouse IL-4 (Genzyme Corporation, Cambridge, Massachusetts) (30 
nglml). 
-w-d- 
Biosynthetic labeling, immunopr&piiions, and SDS-PAGE were 
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carried out as described (Bikoff et al., 1993). In brief, cells were washed 
with warm Hanks’ balanced salt solution containing 2% fetal calf serum 
and antibiotics, and resuspended (2 x lO’/ml) in warm leucine-free 
RPM 1640 supplemented with 4 mM glutamine and 5% dialyzed fetal 
calf serum. After 1 hr at 37OC. PHjleucine was added (250 pCi/ml) for 
40 min. For pulse-labeled samples, cells were immediately harvested, 
washed twice with ice-cold PBS, and the cell pellet was lysed in buffer 
containing 1% NP40,20 mM Tris-HCI (pH 7.5) 150 mM NaCI, 5 mM 
EDTA. 1 mM PMSF, and IO pg/ml aprotinin. After incubation on ice 
for 15 min. extracts were cleared of nuclei and debris by centrifugation 
for 30 min at 15,000 rpm. Alternatively, labeled cells were resuspended 
in a L-fold excess volume of warm RPM1 1640 supplemented as above 
and containing 10 x cold leucine, and incubated at 37OC for 5, 10, or 
16 hr as described in the figure legends. Where indicated, peptides 
(100 uM) were present during the labeling and chase period. Lysates 
were routinely precleared once with rabbit anti-mouse IgG (H plus L) 
antibodies (Zymed, South San Francisco, California), twice with rabbit 
anti-rat IgG (H plus L)antibodies (Zymed, South San Francisco, Califor- 
nia), and twice with protein A-agarose (Bethesda Research Labora- 
tories, Gaithersburg, Maryland), before the addition of specific antibod- 
ies. In the case of rat MAb M5H 14, secondary anti-rat IgG (H plus L) 
antibodies were added to facilitate recovery of immune complexes. 
lmmunoprecipitates were washed three times with buffer containing 
0.05 M Tris-HCI (pH 6) 0.45 M. NaCI, 0.5% NP40,0.05% Na-azide, 
and 1 pg/ml aprotinin, and then solubilized in Laemmli buffer con- 
taining 2% SDS and 2-ME by treatment either for 60 min at room 
temperature or by heating at 100°C for 10 min as indicated in the 
figure legends. Samples were analyzed by SDS-PAGE using 10% 
polyacrylamide gels subsequently treated with EnHance (DuPont- 
NEN, Wilmington, Delaware), dried, and exposed to X-ray film. 
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